Patriot Investment Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
4,236
-919
-18% -$52.8K 0.01% 224
2026
Q1
$313K Sell
5,155
-449
-8% -$26.2K 0.02% 198
2025
Q4
$302K Sell
5,604
-15
-0.3% -$722 0.02% 204
2025
Q3
$253K Sell
5,619
-435
-7% -$20.3K 0.02% 217
2025
Q2
$280K Sell
6,054
-256
-4% -$12.6K 0.02% 208
2025
Q1
$385K Sell
6,310
-74
-1% -$4.31K 0.03% 177
2024
Q4
$361K Sell
6,384
-893
-12% -$49.9K 0.03% 182
2024
Q3
$377K Sell
7,277
-1,623
-18% -$76.1K 0.03% 179
2024
Q2
$370K Sell
8,900
-2,729
-23% -$122K 0.03% 180
2024
Q1
$631K Sell
11,629
-1,140
-9% -$58.1K 0.05% 144
2023
Q4
$655K Sell
12,769
-382
-3% -$20.1K 0.06% 138
2023
Q3
$763K Sell
13,151
-1,584
-11% -$97.1K 0.07% 118
2023
Q2
$942K Sell
14,735
-1,319
-8% -$88.4K 0.08% 113
2023
Q1
$1.11M Sell
16,054
-1,561
-9% -$110K 0.1% 100
2022
Q4
$1.28M Sell
17,615
-3,217
-15% -$243K 0.11% 93
2022
Q3
$1.48M Sell
20,832
-2,187
-10% -$159K 0.15% 80
2022
Q2
$1.77M Sell
23,019
-4,031
-15% -$307K 0.17% 76
2022
Q1
$1.98M Sell
27,050
-785
-3% -$52.7K 0.17% 70
2021
Q4
$1.74M Buy
27,835
+2,298
+9% +$135K 0.15% 79
2021
Q3
$1.51M Buy
25,537
+1,352
+6% +$89K 0.14% 82
2021
Q2
$1.62M Buy
24,185
+1,071
+5% +$69.8K 0.15% 80
2021
Q1
$1.46M Buy
23,114
+534
+2% +$33.2K 0.14% 83
2020
Q4
$1.4M Buy
22,580
+213
+1% +$13.1K 0.21% 56
2020
Q3
$1.35M Buy
22,367
+555
+3% +$33.4K 0.16% 73
2020
Q2
$1.28M Buy
21,812
+1,261
+6% +$75.4K 0.16% 79
2020
Q1
$1.15M Sell
20,551
-3,273
-14% -$200K 0.17% 73
2019
Q4
$1.53M Buy
23,824
+892
+4% +$51.1K 0.2% 67
2019
Q3
$1.15M Buy
22,932
+1,839
+9% +$86.4K 0.16% 84
2019
Q2
$956K Buy
21,093
+1,427
+7% +$66.5K 0.13% 101
2019
Q1
$938K Buy
+19,666
New +$980K 0.14% 99

Other funds holding BMY

Patriot Investment Management Group's BMY Position: Q2 2026 in Review

Patriot Investment Management Group reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, selling an estimated $52.8K and leaving 4,236 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #224.

Patriot Investment Management Group first reported a position in BMY in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.98M in Q1 2022. 988 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Patriot Investment Management Group held 4,236 shares of Bristol-Myers Squibb worth $244K as of Q2 2026.
  • Patriot Investment Management Group sold 919 Bristol-Myers Squibb shares in Q2 2026, an estimated $52.8K.
  • Bristol-Myers Squibb made up 0.01% of Patriot Investment Management Group's portfolio in Q2 2026, its #224 holding.
  • Patriot Investment Management Group first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 30 quarters since.
  • Patriot Investment Management Group's Bristol-Myers Squibb position peaked at $1.98M in Q1 2022.
  • 988 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.